Unusual Adverse Events in a Patient With BRAF-Mutated Non-Small Cell Lung Cancer Treated With BRAF/MEK Inhibition

Maniar, R., Gallitano, S. M., Husain, S., Moazami, G., Weiss, M. J., & Shu, C. A. (2023). Unusual Adverse Events in a Patient With BRAF-Mutated Non–Small Cell Lung Cancer Treated With BRAF/MEK Inhibition. Journal of the National Comprehensive Cancer Network, 21(3), 232–234. https://doi.org/10.6004/jnccn.2022.7084
Authors:
Rohan Maniar
Stephanie M. Gallitano
Sameera Husain
Golnaz Moazami
Michael J. Weiss
Catherine A. Shu
Affiliated Authors:
Rohan Maniar
Stephanie M. Gallitano
Sameera Husain
Golnaz Moazami
Michael J. Weiss
Catherine A. Shu
Author Keywords:
braf mutation
dabrafenib
retinopathy
sweet’s syndrome
trametinib
Publication Type:
Article
Unique ID:
10.6004/jnccn.2022.7084
PMID:
Publication Date:
Data Source:
Scopus

Record Created: